The impact of glycosylation on monoclonal antibody conformation and stability

No abstract is available for this paper.

• Publication year

  2011

• Venue

  mAbs

• Publication date

  2011-11-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.4161/mabs.3.6.17922PMID 22123061PMCID PMC3242843
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ultraviolet spectroscopy as a tool in therapeutic protein development.

  2011cited by this paper
• Glycosylation influences on the aggregation propensity of therapeutic monoclonal antibodies.

  2011cited by this paper
• Use of a folding model and in situ spectroscopic techniques for rational formulation development and stability testing of monoclonal antibody therapeutics.

  2010cited by this paper
• High throughput thermostability screening of monoclonal antibody formulations.

  2010cited by this paper
• Detection of IgG aggregation by a high throughput method based on extrinsic fluorescence.

  2010cited by this paper
• Construction, MD simulation, and hydrodynamic validation of an all-atom model of a monoclonal IgG antibody.

  2010cited by this paper
• Aggregation-prone motifs in human immunoglobulin G.

  2009cited by this paper
• The production of glycoproteins by transient expression in Mammalian cells.

  2009cited by this paper
• Effects of glycosylation on the stability of protein pharmaceuticals.

  2009cited by this paper
• Global antibody development trends

  2009cited by this paper
• Dynamic Fluctuations of Protein-Carbohydrate Interactions Promote Protein Aggregation

  2009cited by this paper
• Design of therapeutic proteins with enhanced stability

  2009cited by this paper
• Using empirical phase diagrams to understand the role of intramolecular dynamics in immunoglobulin G stability.

  2009cited by this paper
• Structural stability of hepatitis C virus envelope glycoprotein E1: effect of pH and dissociative detergents.

  2009cited by this paper
• Effect of the conserved oligosaccharides of recombinant monoclonal antibodies on the separation by protein A and protein G chromatography.

  2009cited by this paper
• Recombinant antibody therapeutics: the impact of glycosylation on mechanisms of action.

  2009cited by this paper
• Evaluation of the physical stability of the EC5 domain of E-cadherin: effects of pH, temperature, ionic strength, and disulfide bonds.

  2009cited by this paper
• Development of a simple and rapid method for producing non‐fucosylated oligomannose containing antibodies with increased effector function

  2008cited by this paper
• Fcγ receptors as regulators of immune responses

  2008cited by this paper
• Fragmentation of a Recombinant Monoclonal Antibody at Various pH

  2008cited by this paper
• pH dependent effect of glycosylation on protein stability.

  2008cited by this paper
• Fcgamma receptors as regulators of immune responses.

  2008cited by this paper
• Structural effect of deglycosylation and methionine oxidation on a recombinant monoclonal antibody.

  2008cited by this paper
• Contribution of variable domains to the stability of humanized IgG1 monoclonal antibodies.

  2008influential reference
• Reversible self-association of a concentrated monoclonal antibody solution mediated by Fab-Fab interaction that impacts solution viscosity.

  2008cited by this paper
• The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability

  2007cited by this paper
• Structural effect of a recombinant monoclonal antibody on hinge region peptide bond hydrolysis.

  2007cited by this paper
• Fc Glycans Terminated with N‐Acetylglucosamine Residues Increase Antibody Resistance to Papain

  2007cited by this paper
• The impact of glycosylation on the biological function and structure of human immunoglobulins.

  2007cited by this paper
• Differences in the glycosylation profile of a monoclonal antibody produced by hybridomas cultured in serum‐supplemented, serum‐free or chemically defined media

  2007cited by this paper
• Glycoform-dependent conformational alteration of the Fc region of human immunoglobulin G1 as revealed by NMR spectroscopy.

  2006cited by this paper
• Glycosylation in the Fc domain of IgG increases resistance to proteolytic cleavage by papain.

  2006cited by this paper
• In vitro galactosylation of human IgG at 1 kg scale using recombinant galactosyltransferase.

  2005cited by this paper
• Non-enzymatic hinge region fragmentation of antibodies in solution.

  2005cited by this paper
• Influence of culture conditions on the N‐glycosylation of a monoclonal antibody specific for recombinant hepatitis B surface antigen

  2005cited by this paper
• Folding mechanism of the CH2 antibody domain.

  2004cited by this paper
• IgG Fc receptors.

  2001cited by this paper
• The influence of glycosylation on the thermal stability and effector function expression of human IgG1-Fc: properties of a series of truncated glycoforms.

  2000cited by this paper
• Glycosylation of human IgG-Fc: influences on structure revealed by differential scanning micro-calorimetry.

  1999influential reference
• Effect of glycosylation on the stability of alpha1-antitrypsin toward urea denaturation and thermal deactivation.

  1997cited by this paper

• Targeting the epidermal growth factor receptor using IgM antibodies: toward next generation cancer immunotherapy

  2026cites this paper
• An Overview of Liquid Chromatography–Mass Spectrometry (LC–MS) Methods for the Quantification of Antibody‐Drug Conjugates

  2026cites this paper
• Architects of folding, editors of immunity: the strategic use of N-glycans in vaccine design.

  2026cites this paper
• Robustness Evaluation of a Legacy N-Glycan Profiling Method for a Therapeutic Antibody Under ICH Q14 Lifecycle Principles

  2026cites this paper
• The Midas touch: Recombinant antibodies transforming diagnostic platforms.

  2026cites this paper
• Biopharmaceutical Analysis by HPLC: Practices and Challenges

  2025cites this paper
• Exploring Protein Aggregation in Biological Products: From Mechanistic Understanding to Practical Solutions

  2025cites this paper
• Monitoring of monoclonal antibody critical quality attributes and free amino acids in CHO bioprocesses using Raman spectroscopy and DUPLEX-based PLS modeling

  2025cites this paper
• Highly Variable Aggregation and Glycosylation Profiles and Their Roles in Immunogenicity to Protein-Based Therapeutics.

  2025cites this paper
• The impact of Fc glycosylation on IgG susceptibility to hinge region chemical reduction: implications for the development of immunoassays

  2025cites this paper
• Proteoform Characterization of HIV-1 Broadly Neutralizing Antibody PGT 121.414.LS Product Through Middle-Up and Bottom-Up Proteomics for Clinical Support.

  2025cites this paper
• Quantifying antibody binding: techniques and therapeutic implications

  2025cites this paper
• Stability of Anti-Drug Antibodies Against Antibody Therapeutics

  2025cites this paper
• Antigen-presenting cell internalization is key for understanding and evaluating therapeutic antibodies’ immunogenicity

  2025cites this paper
• Establishment of reference intervals for serum immunoglobulin G N-glycosylation features in healthy Chinese adults: a nationwide survey in the framework of predictive, preventive, and personalized medicine

  2025cites this paper
• Discovery and Characterization of Novel G0 Glycan Isomers in an Afucosylated Therapeutic Antibody Using Liquid Chromatography-Mass Spectrometry.

  2025cites this paper
• Clinical Scaleup of Humanized AnnA1 Antibody Yielded Unexpected High Reticuloendothelial (RES) Uptake in Mice

  2025cites this paper
• Continuous glucose feedback control using Raman spectroscopy and deep learning models for biopharmaceutical processes

  2025cites this paper
• Comparative Analysis of Glycan Composition in Therapeutic Antibodies via Glycan Profiling and Intact Mass Analysis

  2025cites this paper
• Directional conjugation of monoclonal antibodies to nanoparticles using metal-free click chemistry.

  2025cites this paper
• Beyond In Vivo, Pharmaceutical Molecule Production in Cell-Free Systems and the Use of Noncanonical Amino Acids Therein

  2025cites this paper
• Design of bispecific antibody Fc region employing a shark-human chimeric and asymmetric format.

  2025cites this paper
• Plant-related quality attributes affecting FcγRIIIa binding: affinity chromatography analysis of rituximab glycovariants from Nicotiana benthamiana

  2025cites this paper
• Comparative Biophysical and Functional Analysis of TCZ-UFRJ, a Potential Biosimilar to Actemra.

  2025cites this paper
• The nonglycosylated variant in therapeutic monoclonal antibodies preferentially forms large aggregates under typical thermal stresses used in forced degradation studies

  2025cites this paper
• Evaluation of the impact of antibody fragments on aggregation of intact molecules via size exclusion chromatography coupled with native mass spectrometry

  2024cites this paper
• An important consideration when expressing mAbs in Escherichia coli.

  2024cites this paper
• Using capillary electrophoresis sodium dodecyl sulfate (CE‐SDS) and liquid chromatograph mass spectrometry (LC–MS) to identify glycosylated heavy chain heterogeneity in the anti‐VEGFR‐2 monoclonal antibody

  2024cites this paper
• A comprehensive review and analysis of patents on biological and biosimilar products listed in the purple book

  2024cites this paper
• The potential of polyaniline-coated stationary phase in hydrophilic interaction liquid chromatography-based solid-phase extraction for glycopeptide enrichment.

  2024cites this paper
• Impact of Glycosylation on Protein-Protein Self-Interactions of Monoclonal Antibodies.

  2024cites this paper
• Hybrid Mass Spectrometry Applied across the Production of Antibody Biotherapeutics

  2024cites this paper
• Antibody Aggregation: A Problem Within the Biopharmaceutical Industry and Its Role in AL Amyloidosis Disease

  2024cites this paper
• Biophysical Analysis of Therapeutic Antibodies in the Early Development Pipeline

  2024cites this paper
• Revisiting the immunopathology of congenital disorders of glycosylation: an updated review

  2024cites this paper
• Enhancing monoclonal antibody production efficiency using CHO-MK cells and specific media in a conventional fed-batch culture

  2024cites this paper
• The IgG-specific endoglycosidases EndoS and EndoS2 are distinguished by conformation and antibody recognition.

  2024cites this paper
• Emerging conjugation strategies and protein engineering technologies aim to improve ADCs in the fight against cancer

  2024cites this paper
• Ion Mobility-Mass Spectrometry and Collision-Induced Unfolding Rapidly Characterize the Structural Polydispersity and Stability of an Fc-Fusion Protein.

  2024cites this paper
• Impact of sunitinib resistance on clear cell renal cell carcinoma therapeutic sensitivity in vitro

  2024cites this paper
• Development of a Novel Label-Free Subunit HILIC-MS Method for Domain-Specific Free Thiol Identification and Quantitation in Therapeutic Monoclonal Antibodies

  2024cites this paper
• The Power of Reagent Titration in Flow Cytometry

  2024cites this paper
• Survey of Chemical Unfolding Complexity as a Unique Stability Assessment Assay for Monoclonal Antibodies

  2024cites this paper
• From Lab to Clinic: The Production of Different Types of Recombinant Antibodies as Cancer Treatments

  2024cites this paper
• In silico mediated workflow for rapid development of downstream processing: Orthogonal product-related impurity removal for a Fc-containing therapeutic.

  2024cites this paper
• Analysis of Beyfortus® (Nirsevimab) Immunization Campaign: Effectiveness, Biases, and ADE Risks in RSV Prevention

  2024cites this paper
• Direct glycosylation analysis of intact monoclonal antibodies combining ESI MS of glycoforms and MALDI-in source decay MS of glycan fragments

  2024cites this paper
• Living in LALA land? Forty years of attenuating Fc effector functions

  2024cites this paper
• Glycosylation: mechanisms, biological functions and clinical implications

  2024cites this paper
• Assessing the Manufacturability and Critical Quality Attribute Profiles of Anti-IL-8 Immunoglobulin G Mutant Variants

  2024cites this paper
• Exploring the structural heterogeneity of IgG1s: A comprehensive analysis of glycosylated and deglycosylated forms using TIMS-TOF-MS technique

  2024cites this paper
• Liquid-phase separations coupled with ion mobility-mass spectrometry for next-generation biopharmaceutical analysis

  2024cites this paper
• Escherichia coli and Pichia pastoris: microbial cell-factory platform for full-length IgG production

  2024cites this paper
• Smart Nanoscale Extracellular Vesicles in the Brain: Unveiling their Biology, Diagnostic Potential, and Therapeutic Applications.

  2024cites this paper
• Site‐Specific Modification of Native IgGs with Flexible Drug‐Load

  2024cites this paper
• Establishing a Cell-Free Glycoprotein Synthesis System for Enzymatic N-GlcNAcylation.

  2024cites this paper
• Interaction of Asn297-Linked Glycan Ligands with the Fc Fragment of the Immunoglobulin Class G1: A Molecular Dynamics Simulation Study

  2024cites this paper
• Enhanced N-Glycan Profiling of Therapeutic Monoclonal Antibodies through the Application of Upper-Hinge Middle-Up Level LC-HRMS Analysis

  2024cites this paper
• Homogeneous multi-payload antibody–drug conjugates

  2024cites this paper
• Mapping of the gene network that regulates glycan clock of ageing

  2023cites this paper
• Enhancing pharmacokinetic and pharmacodynamic properties of recombinant therapeutic proteins by manipulation of sialic acid content.

  2023cites this paper
• IgG glycans in health and disease: Prediction, intervention, prognosis, and therapy.

  2023cites this paper
• COVID-19 Therapeutics: Use, Mechanism of Action, and Toxicity (Vaccines, Monoclonal Antibodies, and Immunotherapeutics)

  2023cites this paper
• Ion Mobility-Mass Spectrometry and Collision-Induced Unfolding of Designed Bispecific Antibody Therapeutics.

  2023cites this paper
• In vivo deglycosylation of recombinant glycoproteins in tobacco BY‐2 cells

  2023influential citation
• Online Collision-Induced Unfolding of Therapeutic Monoclonal Antibody Glyco-Variants through Direct Hyphenation of Cation Exchange Chromatography with Native Ion Mobility–Mass Spectrometry

  2023cites this paper
• Progress in Top-Down LC-MS Analysis of Antibodies: Review

  2023cites this paper
• Chemical technology principles for selective bioconjugation of proteins and antibodies.

  2023cites this paper
• Engineering CD276/B7-H3-targeted antibody-drug conjugates with enhanced cancer-eradicating capability

  2023cites this paper
• Structural modifications for the conversion of proteins and peptides into stable dried powder formulations: A review

  2023cites this paper
• Multiple N-linked glycosylation sites critically modulate the synaptic abundance of neuroligin isoforms

  2023cites this paper
• An oligosaccharyltransferase from Leishmania donovani increases the N-glycan occupancy on plant-produced IgG1

  2023cites this paper
• Expedited Evaluation of Conformational Stability-Heterogeneity Associations for Crude Polyclonal Antibodies in Response to Conjugate Vaccines.

  2023cites this paper
• Bespoke conformation and antibody recognition distinguishes the streptococcal immune evasion factors EndoS and EndoS2

  2023cites this paper
• Glycosylation shapes the efficacy and safety of diverse protein, gene and cell therapies.

  2023cites this paper
• Enhanced Stability Differentiation of Therapeutic Polyclonal Antibodies with All Ion Unfolding-Ion Mobility-Mass Spectrometry.

  2023cites this paper
• Understanding and controlling the molecular mechanisms of protein aggregation in mAb therapeutics.

  2023cites this paper
• Cation exchange chromatography on a monodisperse 3 µm particle enables extensive analytical similarity assessment of biosimilars.

  2023cites this paper
• In Silico Analysis of Therapeutic Antibody Aggregation and the Influence of Glycosylation.

  2022cites this paper
• Full-length recombinant antibodies from Escherichia coli: production, characterization, effector function (Fc) engineering, and clinical evaluation

  2022cites this paper
• The Mannose in the Mirror: A Reflection on the Pharmacokinetic Impact of High Mannose Glycans of Monoclonal Antibodies in Biosimilar Development

  2022cites this paper
• The manufacturing considerations of bispecific antibodies

  2022cites this paper
• The In � uence of N-Linked Glycans on the Molecular Dynamics of the HIV-1 gp 120 V 3 Loop

  2022cites this paper
• A mouse pancreatic organoid model to compare PD-L1 blocking antibodies

  2022cites this paper
• N-Glycosylation of monoclonal antibody therapeutics: A comprehensive review on significance and characterization.

  2022cites this paper
• Impact of Drug Conjugation on Thermal and Metabolic Stabilities of Aglycosylated and N-Glycosylated Antibodies

  2022cites this paper
• Coupling Anion Exchange Chromatography with Native Mass Spectrometry for Charge Heterogeneity Characterization of Monoclonal Antibodies

  2022cites this paper
• A high-resolution multi-attribute method for product characterization, process characterization, and quality control of therapeutic proteins.

  2022cites this paper
• Streamlining the Characterization of Disulfide Bond Shuffling and Protein Degradation in IgG1 Biopharmaceuticals Under Native and Stressed Conditions

  2022cites this paper
• Advances of research of Fc-fusion protein that activate NK cells for tumor immunotherapy.

  2022cites this paper
• Non-targeted characterization of attributes affecting antibody-FcγRIIIa V158 (CD16a) binding via online affinity chromatography-mass spectrometry

  2022cites this paper
• High-Pressure, Low-Temperature Induced Unfolding and Aggregation of Monoclonal Antibodies: Role of the Fc and Fab Fragments.

  2022cites this paper
• Antibody-dependent cellular cytotoxicity-null effector developed using mammalian and plant GlycoDelete platform

  2022cites this paper
• Analysis of Biologics Molecular Descriptors towards Predictive Modelling for Protein Drug Development Using Time-Gated Raman Spectroscopy

  2022cites this paper
• Enhanced transglycosylation activity of an Endo-F3 mutant by ligand-directed localization.

  2022cites this paper
• Developability profiling of a panel of Fc engineered SARS-CoV-2 neutralizing antibodies

  2022cites this paper
• Monoclonal Antibodies: Discovery and Protein Engineering

  2021cites this paper
• Stability Assessment of FDA Approved Ramucirumab Monoclonal Antibody; Validated SE-HPLC Method for Degradation Pattern Evaluation.

  2021cites this paper
• Site-Selective and Biocompatible Growth of Polymers from Glycan Moieties of Glycoproteins and Living Cells.

  2021cites this paper
• Peptide Inhibitors of Vascular Endothelial Growth Factor A: Current Situation and Perspectives

  2021cites this paper